These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 19469193
21. Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting. Barlis P, Horrigan M, Elis S, Chan R, Wong M, Farouque O, Proimos G, Ajani AE, Clark DJ. Cardiovasc Revasc Med; 2007; 8(2):84-9. PubMed ID: 17574165 [Abstract] [Full Text] [Related]
26. Angiographic restenosis and clinical recurrence after sirolimus- and paclitaxel-eluting stent implantation. Vlaar PJ, Zijlstra F. JACC Cardiovasc Interv; 2009 Aug; 2(8):776-8. PubMed ID: 19695547 [No Abstract] [Full Text] [Related]
27. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis. Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Hong MK, Park SW, Park SJ. J Am Coll Cardiol; 2010 Jun 08; 55(23):2544-52. PubMed ID: 20513593 [Abstract] [Full Text] [Related]
28. A critical appraisal of the Janus carbostent. Kornowski R. Catheter Cardiovasc Interv; 2009 Feb 01; 73(2):249-50. PubMed ID: 19156897 [No Abstract] [Full Text] [Related]
29. Myocardial revascularization: PCI/stent or coronary artery bypass graft-what is best for our patients? Richard Conti C. Clin Cardiol; 2009 Nov 01; 32(11):606-7. PubMed ID: 19938044 [Abstract] [Full Text] [Related]
30. Simultaneous quadruple kissing stenting of an unprotected left main coronary artery. Dubois CL, Kayaert P, Desmet W. Eur Heart J; 2010 Feb 01; 31(4):488. PubMed ID: 19942603 [No Abstract] [Full Text] [Related]
31. Another quest for a solution... and when a dedicated device? Bonan R. Catheter Cardiovasc Interv; 2009 Nov 01; 74(5):691-2. PubMed ID: 19856430 [No Abstract] [Full Text] [Related]
32. Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial. Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H. JACC Cardiovasc Interv; 2015 Jan 01; 8(1 Pt A):30-8. PubMed ID: 25499302 [Abstract] [Full Text] [Related]
33. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. White AJ, Kedia G, Mirocha JM, Lee MS, Forrester JS, Morales WC, Dohad S, Kar S, Czer LS, Fontana GP, Trento A, Shah PK, Makkar RR. JACC Cardiovasc Interv; 2008 Jun 01; 1(3):236-45. PubMed ID: 19463306 [Abstract] [Full Text] [Related]
39. Percutaneous coronary intervention as an alternative to bypass surgery for unprotected LMCA stenosis. Park SJ, Kim YH. Expert Rev Cardiovasc Ther; 2008 Sep 01; 6(8):1107-14. PubMed ID: 18793113 [Abstract] [Full Text] [Related]
40. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2. Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice MC, Carrie D, van Es GA, Nagai H, Detiege D, Paunovic D, Serruys PW, NOBORI 1 Clinical Investigators. Circ Cardiovasc Interv; 2009 Jun 01; 2(3):188-95. PubMed ID: 20031715 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]